Article Versions Notes

Dima D, Ullah F, Mazzoni S, Williams L, Faiman B, Kurkowski A, Chaulagain C, Raza S, Samaras C, Valent J, et al. Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice. Cancers. 2023; 15(7):2160. https://doi.org/10.3390/cancers15072160

Dima, Danai, Fauzia Ullah, Sandra Mazzoni, Louis Williams, Beth Faiman, Austin Kurkowski, Chakra Chaulagain, Shahzad Raza, Christy Samaras, Jason Valent, and et al. 2023. "Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice" Cancers 15, no. 7: 2160. https://doi.org/10.3390/cancers15072160

Dima, D., Ullah, F., Mazzoni, S., Williams, L., Faiman, B., Kurkowski, A., Chaulagain, C., Raza, S., Samaras, C., Valent, J., Khouri, J., & Anwer, F. (2023). Management of Relapsed–Refractory Multiple Myeloma in the Era of Advanced Therapies: Evidence-Based Recommendations for Routine Clinical Practice. Cancers, 15(7), 2160. https://doi.org/10.3390/cancers15072160